Square Pharmaceuticals PLC. reported earnings results for the third quarter ended September 30, 2024. For the third quarter, the company reported sales was BDT 17,746.89 million compared to BDT 17,811.24 million a year ago. Net income was BDT 6,091.92 million compared to BDT 6,000.38 million a year ago. Basic earnings per share from continuing operations was BDT 6.87 compared to BDT 6.77 a year ago.